Lam Research Corporation $LRCX Shares Acquired by Panagora Asset Management Inc.
by Amy Steele · The Cerbat GemPanagora Asset Management Inc. boosted its holdings in Lam Research Corporation (NASDAQ:LRCX – Free Report) by 1.4% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 832,578 shares of the semiconductor company’s stock after buying an additional 11,461 shares during the period. Panagora Asset Management Inc.’s holdings in Lam Research were worth $81,043,000 at the end of the most recent reporting period.
Other institutional investors also recently made changes to their positions in the company. Norges Bank acquired a new stake in Lam Research during the second quarter worth about $1,894,585,000. Vanguard Group Inc. raised its holdings in shares of Lam Research by 6.9% during the 1st quarter. Vanguard Group Inc. now owns 129,152,102 shares of the semiconductor company’s stock valued at $9,389,358,000 after buying an additional 8,364,375 shares during the period. Nuveen LLC acquired a new position in Lam Research during the 1st quarter worth approximately $604,344,000. JPMorgan Chase & Co. boosted its stake in shares of Lam Research by 14.4% in the second quarter. JPMorgan Chase & Co. now owns 40,622,437 shares of the semiconductor company’s stock valued at $3,954,188,000 after purchasing an additional 5,102,589 shares during the period. Finally, Price T Rowe Associates Inc. MD increased its stake in Lam Research by 99.7% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 5,739,221 shares of the semiconductor company’s stock worth $417,242,000 after buying an additional 2,864,863 shares during the period. 84.61% of the stock is owned by hedge funds and other institutional investors.
Insiders Place Their Bets
In related news, SVP Vahid Vahedi sold 52,190 shares of Lam Research stock in a transaction dated Monday, October 13th. The shares were sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the sale, the senior vice president directly owned 251,047 shares in the company, valued at $34,870,428.30. The trade was a 17.21% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Douglas R. Bettinger sold 40,080 shares of the stock in a transaction dated Friday, November 14th. The shares were sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the completion of the transaction, the chief financial officer owned 987,237 shares of the company’s stock, valued at $148,677,892.20. This represents a 3.90% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 102,608 shares of company stock worth $14,916,496. Insiders own 0.31% of the company’s stock.
Analyst Upgrades and Downgrades
LRCX has been the subject of a number of research analyst reports. Cowen restated a “buy” rating on shares of Lam Research in a research note on Thursday, October 23rd. Barclays set a $142.00 price objective on shares of Lam Research and gave the stock an “equal weight” rating in a report on Monday, October 20th. B. Riley boosted their target price on shares of Lam Research from $160.00 to $175.00 and gave the stock a “buy” rating in a research report on Monday, October 20th. Susquehanna increased their price target on shares of Lam Research from $135.00 to $200.00 and gave the stock a “positive” rating in a research report on Thursday, October 23rd. Finally, BNP Paribas Exane lifted their price target on Lam Research from $80.00 to $140.00 and gave the stock a “neutral” rating in a research note on Thursday, October 23rd. Twenty-six equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. According to MarketBeat, Lam Research has an average rating of “Moderate Buy” and a consensus target price of $152.17.
Check Out Our Latest Stock Report on LRCX
Lam Research Stock Down 0.1%
NASDAQ:LRCX opened at $154.95 on Monday. Lam Research Corporation has a 52 week low of $56.32 and a 52 week high of $167.15. The company has a current ratio of 2.21, a quick ratio of 1.60 and a debt-to-equity ratio of 0.37. The stock has a 50 day moving average of $147.23 and a 200-day moving average of $114.99. The firm has a market capitalization of $194.62 billion, a PE ratio of 34.13, a price-to-earnings-growth ratio of 1.68 and a beta of 1.87.
Lam Research (NASDAQ:LRCX – Get Free Report) last posted its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 EPS for the quarter, topping the consensus estimate of $1.22 by $0.04. The firm had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.23 billion. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. Lam Research’s quarterly revenue was up 27.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Analysts predict that Lam Research Corporation will post 3.71 EPS for the current year.
Lam Research Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 7th. Shareholders of record on Wednesday, December 3rd will be paid a dividend of $0.26 per share. The ex-dividend date of this dividend is Wednesday, December 3rd. This represents a $1.04 annualized dividend and a yield of 0.7%. Lam Research’s payout ratio is presently 22.91%.
Lam Research Profile
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.
See Also
- Five stocks we like better than Lam Research
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Worried About Inflation? These 3 ETFs Offer Real Protection
- What is the Dow Jones Industrial Average (DJIA)?
- Intel’s Black Friday Breakout: Apple Rumors Fuel a Holiday Rally
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Klarna’s Crypto Play: A Plan to Fix Its Profit Problem
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX – Free Report).